tiprankstipranks
Indo Amines Limited (IN:INDOAMIN)
:INDOAMIN
India Market

Indo Amines Limited (INDOAMIN) AI Stock Analysis

0 Followers

Top Page

IN:INDOAMIN

Indo Amines Limited

(INDOAMIN)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
₹101.00
▼(-21.55% Downside)
Action:ReiteratedDate:04/02/26
The score is driven primarily by strong financial performance (revenue growth and improving margins) but is meaningfully offset by negative free cash flow and weak technicals (below key moving averages with bearish MACD and low RSI). Valuation is reasonable but the dividend yield is low, offering limited support.
Positive Factors
Revenue Growth
Indo Amines reported a notable top-line increase from 2024 to 2025 (RevenueGrowth ~7.76% and EPS growth ~28.6%), showing durable demand across its industrial end markets. Consistent revenue expansion supports scale, customer retention, and long-term investment in specialty product capabilities.
Negative Factors
Negative Free Cash Flow
Negative free cash flow in 2025, despite solid operating cash conversion, signals cash absorbtion (likely from capex or working capital). If sustained, negative FCF constrains the company's ability to self-fund growth, reduce leverage, or return capital, forcing reliance on external financing or curtailed investments.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Indo Amines reported a notable top-line increase from 2024 to 2025 (RevenueGrowth ~7.76% and EPS growth ~28.6%), showing durable demand across its industrial end markets. Consistent revenue expansion supports scale, customer retention, and long-term investment in specialty product capabilities.
Read all positive factors

Indo Amines Limited (INDOAMIN) vs. iShares MSCI India ETF (INDA)

Indo Amines Limited Business Overview & Revenue Model

Company Description
Indo Amines Limited manufactures, develops, and supplies fine chemicals, specialty chemicals, performance chemicals, perfumery chemicals, and active pharmaceuticals ingredients worldwide. The company's fine chemicals comprise aliphatic and aromati...
How the Company Makes Money
Indo Amines primarily makes money by manufacturing and selling chemical products (amines and related specialty/intermediate chemicals) to industrial customers. Revenue is generated through (1) product sales of its amines/specialty chemical portfol...

Indo Amines Limited Financial Statement Overview

Summary
Strong revenue growth and improving profitability support the score, with a solid gross margin (25.5%) and higher net margin (5.2%). Balance sheet leverage is moderate (debt-to-equity 0.9) with a healthy equity ratio (40.7%), but cash flow is a key drag due to negative free cash flow in 2025 despite good operating cash generation (operating cash flow to net income 1.25).
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue11.09B10.79B9.40B9.41B7.79B5.34B
Gross Profit3.28B2.75B2.20B2.30B1.91B1.52B
EBITDA1.36B1.16B936.55M913.41M604.51M679.67M
Net Income701.15M558.95M428.13M408.75M230.47M374.83M
Balance Sheet
Total Assets8.43B7.79B6.33B5.97B5.54B4.53B
Cash, Cash Equivalents and Short-Term Investments223.97M167.79M55.89M60.73M61.66M44.88M
Total Debt3.07B2.84B2.17B2.32B2.07B1.59B
Total Liabilities4.83B4.61B3.70B3.71B3.67B2.91B
Stockholders Equity3.60B3.17B2.63B2.25B1.87B1.63B
Cash Flow
Free Cash Flow-81.70M-216.82M391.02M-109.75M-242.71M57.73M
Operating Cash Flow363.28M697.01M696.71M203.63M154.59M561.79M
Investing Cash Flow-375.71M-904.58M-265.64M-298.27M-388.40M-496.60M
Financing Cash Flow66.32M153.96M-408.70M40.26M319.15M-11.24M

Indo Amines Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price128.75
Price Trends
50DMA
104.97
Negative
100DMA
114.77
Negative
200DMA
130.53
Negative
Market Momentum
MACD
-1.95
Negative
RSI
57.81
Neutral
STOCH
94.03
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDOAMIN, the sentiment is Neutral. The current price of 128.75 is above the 20-day moving average (MA) of 94.29, above the 50-day MA of 104.97, and below the 200-day MA of 130.53, indicating a neutral trend. The MACD of -1.95 indicates Negative momentum. The RSI at 57.81 is Neutral, neither overbought nor oversold. The STOCH value of 94.03 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:INDOAMIN.

Indo Amines Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹6.71B17.610.81%33.39%85.08%
64
Neutral
₹7.51B19.710.38%13.01%32.44%
62
Neutral
₹11.49B17.660.52%28.67%50.12%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
56
Neutral
₹8.13B697.5115.56%2114.71%
49
Neutral
₹7.53B-10.640.39%
46
Neutral
₹6.71B-247.220.34%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:INDOAMIN
Indo Amines Limited
103.51
-14.87
-12.56%
IN:BHAGERIA
Bhageria Industries Ltd.
153.75
-0.12
-0.08%
IN:BODALCHEM
Bodal Chemicals Limited
64.58
4.46
7.42%
IN:HERANBA
Heranba Industries Limited
188.30
-47.68
-20.21%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
355.20
124.32
53.85%
IN:UNIENTER
Uniphos Enterprises Limited
96.51
-53.75
-35.77%

Indo Amines Limited Corporate Events

Indo Amines Publishes Q3 FY2025 Unaudited Results in Mumbai Dailies
Feb 8, 2026
Indo Amines Limited has announced that its unaudited financial results for the quarter and nine months ended 31 December 2025 have been published in leading Mumbai newspapers The Free Press Journal and Navshakti, in line with regulatory disclosure...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 02, 2026